<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Padra M</submitter><funding>the Royal Physiographic Society of Lund</funding><funding>the Alfred Österlund Foundation</funding><funding>the Swedish Government Funds for Clinical Research</funding><funding>the Swedish Research Council</funding><funding>the Swedish Heart and Lung Foundation</funding><pagination>612-622</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12498364</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>73(4)</volume><pubmed_abstract>Allergic asthma is characterized by Type 2 inflammation and eosinophilia. Tartrate-resistant acid phosphatase 5 (TRAP5; also referred to as acid phosphatase 5 [ACP5]) is a metallophosphatase expressed by alveolar macrophages that dephosphorylates osteopontin, a phosphoglycoprotein with increased expression in asthma. To investigate the role of TRAP5 during asthma, we used a murine model of ovalbumin (OVA)-induced allergic airway inflammation as well as IL-33-induced airway inflammation, including &lt;i>Trap&lt;/i&gt;5&lt;sup>-/-&lt;/sup> and wild-type (WT) mice. Histological analyses of murine lung revealed that OVA-induced inflammation induced the formation of inflammatory lesions and increased mucus production in both WT and &lt;i>Trap&lt;/i>5&lt;sup>-/-&lt;/sup> mice. However, lower cytokine levels (including IL-</pubmed_abstract><journal>American journal of respiratory cell and molecular biology</journal><pubmed_title>Tartrate-Resistant Acid Phosphatase 5 (TRAP5) Promotes Eosinophil Migration During Allergic Asthma.</pubmed_title><pmcid>PMC12498364</pmcid><funding_grant_id>46402</funding_grant_id><funding_grant_id>20220193</funding_grant_id><funding_grant_id>2023-02013</funding_grant_id><pubmed_authors>Padra M</pubmed_authors><pubmed_authors>Egesten A</pubmed_authors><pubmed_authors>Marcoux G</pubmed_authors><pubmed_authors>Bhongir RKV</pubmed_authors><pubmed_authors>Bergwik J</pubmed_authors><pubmed_authors>Papareddy P</pubmed_authors><pubmed_authors>Adler A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tartrate-Resistant Acid Phosphatase 5 (TRAP5) Promotes Eosinophil Migration During Allergic Asthma.</name><description>Allergic asthma is characterized by Type 2 inflammation and eosinophilia. Tartrate-resistant acid phosphatase 5 (TRAP5; also referred to as acid phosphatase 5 [ACP5]) is a metallophosphatase expressed by alveolar macrophages that dephosphorylates osteopontin, a phosphoglycoprotein with increased expression in asthma. To investigate the role of TRAP5 during asthma, we used a murine model of ovalbumin (OVA)-induced allergic airway inflammation as well as IL-33-induced airway inflammation, including &lt;i>Trap&lt;/i&gt;5&lt;sup>-/-&lt;/sup> and wild-type (WT) mice. Histological analyses of murine lung revealed that OVA-induced inflammation induced the formation of inflammatory lesions and increased mucus production in both WT and &lt;i>Trap&lt;/i>5&lt;sup>-/-&lt;/sup> mice. However, lower cytokine levels (including IL-</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T04:50:04.358Z</modification><creation>2026-05-05T03:12:43.783Z</creation></dates><accession>S-EPMC12498364</accession><cross_references><pubmed>40173299</pubmed><doi>10.1165/rcmb.2024-0304OC</doi></cross_references></HashMap>